Research institute
In a recent study published in Scientific Reports, researchers at Kanazawa University show that an artificially synthesized molecule can exhibit compatible activities to natural molecules in its biological effectiveness.
Researchers with Iowa-based Cellular Engineering Technologies, the John Paul II Medical Research Institute and the University of Iowa published research in late 2018 describing a safer and ethical method of creating pluripotent stem cells from cord blood and peripheral blood.
Researchers at The University of Texas MD Anderson Cancer Center have discovered an immune regulator that appears to dictate glioblastoma (GBM) progression by shutting down immune surveillance, indicating a potential new area of therapeutic investigation.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Cancer Research UK, a cancer research and awareness charity in the United Kingdom and Isle of Man, recently announced its latest Grand Challenge winners. This cancer research grant awards a series of £20 million wards to international, multidisciplinary teams that focus on unique and new approaches to cancer.
Scientists at DZNE, the Hertie Institute for Clinical Brain Research (HIH) and the University Hospital Tuebingen identified a protein in blood that can precisely track Alzheimer’s disease progression before the first symptoms appear.
Researchers from A*STAR’s SBIC have discovered how changes in BCAA metabolism influence the development and progression of tumours, and pave the way for new approaches to prevent and treat certain cancers
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
The University of Texas MD Anderson Cancer Centerand Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly’s TriNKET™ (tri-specific natural killer cell engager therapy) immunotherapy drug candidates to patients in clinical trials beginning in 2019.
Artificial intelligence technology has an established home in drug design for many developers. Now, researchers are seeing it as a potential tool in driving therapeutic choices in the treatment of ovarian cancer.
PRESS RELEASES